Replies to post #173553 on Biotech Values

[GrthzGd]

RARE up >2X; CARA up 30%; TRVN down 5%

[DewDiligence]

Especially for ‘mcbio’—TRVN could be your kind of company based on its minuscule EV of <$100M:

http://finance.yahoo.com/news/trevena-reports-second-quarter-2014-110000245.html

TRVN IPOd in Jan 2014 at $7/sh and is trading below that level now.

No recommendation implied!